Displaying 1 - 20 of 4968
Statement of Chairwoman Edith Ramirez and Commissioner Julie Brill Federal Trade Commission - In the Matter of Ferrellgas Partners, L.P., et al.
Federal Trade Commission Act
Clayton Act
Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin)
The FTC filed a lawsuit against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs.
On February 4, 2026, the Federal Trade Commission secured a landmark settlement with Express Scripts, Inc., and its affiliated entities (collectively “ESI”). The settlement requires ESI to adopt fundamental changes to its business practices that increase transparency, are expected to drive down patients’ out-of-pocket costs for drugs like insulin by up to $7 billion over 10 years, bring millions of dollars in new revenue to community pharmacies each year, and advance the Trump Administration’s key healthcare priorities.
Federal Trade Commission and Department of Justice Seek Public Comment on the Premerger Notification and Report Form
FTC Chairman Andrew N. Ferguson Launches Healthcare Task Force
FTC Stops Proposed Merger of Leading Cataract-Surgery Device Makers
An Atlas of US Physician Practice Choice and Firm Structure: 2015-2020, for Selected States from the FTC Physician and Facility Merger Study
Granting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules
Federal Trade Commission and Department of Justice Seek Public Comment for Guidance on Business Collaborations
Granting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules
FTC Finalizes Consent Order in Boeing, Spirit Acquisition
The Boeing Co. /Spirit AeroSystems Holdings
The Federal Trade Commission will require The Boeing Company (Boeing) to divest significant Spirit AeroSystems Holdings, Inc. (Spirit) assets to resolve antitrust concerns surrounding Boeing’s $8.3 billion acquisition of Spirit.
On February 17, 2026, the FTC finalized the consent order in this matter.